文献速递血脂与心血管预防

高脂蛋白(a)浓度在亲属中的一致性

Concordance of a High Lipoprotein(a) Concentration Among Relatives.
PubMed 文献 · JAMA Cardiol · 2023-01-01

基于英国生物银行52 418名参与者的横断面分析显示,高Lp(a)(≥125 nmol/L)先证者的一级亲属中47.0%也存在高Lp(a),二级亲属为31.8%,均高于无亲缘关系对照的16.4%。一级亲属和二级亲属的比值比分别为7.4和3.0,支持对高Lp(a)者的一级亲属进行级联筛查。

要点

  • 高Lp(a)先证者的一级亲属中近半数(47.0%)Lp(a)也升高。
  • 二级亲属高Lp(a)一致性为31.8%,仍高于无亲缘对照的16.4%。
  • 一级亲属和二级亲属的比值比分别为7.4和3.0。

核心结论

  • 高Lp(a)先证者的一级亲属中级联筛查检出高Lp(a)的收益超过40%。

研究设计与样本

  • 横断面分析纳入英国生物银行52 418名参与者,比较一级亲属(n=19 899对)、二级亲属(n=9 715对)与无亲缘随机配对(n=184 764对)的高Lp(a)一致性。

主要发现

  • 一级亲属Lp(a)相关性Spearman ρ=0.45(P<.001),二级亲属ρ=0.22(P<.001)。
  • 高Lp(a)先证者的一级亲属中47.0%(95%CI 45.3%-48.7%)Lp(a)升高,二级亲属中31.8%(95%CI 29.6%-34.2%),无亲缘配对中16.4%(95%CI 16.0%-16.9%)。
  • 一级亲属比值比7.4(95%CI 6.8-8.1),二级亲属比值比3.0(95%CI 2.7-3.4)。
  • 亚组(既往ASCVD、绝经后女性、他汀使用者)中高Lp(a)一致性基本一致。

关键数值与推荐

  • 高Lp(a)定义为至少125 nmol/L。

临床怎么用

  • 对高Lp(a)个体的一级亲属进行级联筛查,有助于识别额外的ASCVD风险个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Lipoprotein(a) (Lp[a]) concentrations are a highly heritable and potential causal risk factor for atherosclerotic cardiovascular disease (ASCVD). Recent consensus statements by the European Atherosclerosis Society and American Heart Association recommend screening of relatives of individuals with high Lp(a) concentrations, but the expected yield of this approach has not been quantified in large populations. OBJECTIVE: To measure the prevalence of high Lp(a) concentrations among first- and second-degree relatives of individuals with high Lp(a) concentrations compared with unrelated participants. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional analysis, pairs of first-degree (n = 19 899) and second-degree (n = 9715) relatives with measured Lp(a) levels from the UK Biobank study and random pairs of unrelated individuals (n = 184 764) were compared. Data for this study were collected from March 2006 to August 2010 and analyzed from December 2021 to August 2023. EXPOSURE: Serum Lp(a) levels, with a high Lp(a) level defined as at least 125 nmol/L. MAIN OUTCOME AND MEASURE: Concordance of clinically relevant high Lp(a) levels in first- and second-degree relatives of index participants with high Lp(a) levels. RESULTS: A total of 52 418 participants were included in the analysis (mean [SD] age, 57.3 [8.0] years; 29 825 [56.9%] women). Levels of Lp(a) were correlated among pairs of first-degree (Spearman ρ = 0.45; P < .001) and second-degree (Spearman ρ = 0.22; P < .001) relatives. A total of 1607 of 3420 (47.0% [95% CI, 45.3%-48.7%]) first-degree and 514 of 1614 (31.8% [95% CI, 29.6%-34.2%]) second-degree relatives of index participants with high Lp(a) levels also had elevated concentrations compared with 4974 of 30 258 (16.4% [95% CI, 16.0%-16.9%]) pairs of unrelated individuals. The concordance in high Lp(a) levels was generally consistent among subgroups (eg, those with prior ASCVD, postmenopausal women, and statin users). The odds ratios for relatives to have high Lp(a) levels if their index relative had a high Lp(a) level compared with those whose index relatives did not have high Lp(a) levels were 7.4 (95% CI, 6.8-8.1) for first-degree relatives and 3.0 (95% CI, 2.7-3.4) for second-degree relatives. CONCLUSIONS AND RELEVANCE: The findings of this cross-sectional study suggest that the yield of cascade screening of first-degree relatives of individuals with high Lp(a) levels is over 40%. These findings support recent recommendations to use this approach to identify additional individuals at ASCVD risk based on Lp(a) concentrations.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Reeskamp LF, Tromp TR, Patel AP, et al. Concordance of a High Lipoprotein(a) Concentration Among Relatives. JAMA Cardiol. 2023. PMID: 37819667. doi:10.1001/jamacardio.2023.3548

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。